These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2272179)

  • 21. Abnormal platelet function in myeloproliferative disorders.
    Waddell CC; Brown JA; Repinecz YA
    Arch Pathol Lab Med; 1981 Aug; 105(8):432-5. PubMed ID: 6894852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations.
    Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G
    Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelets in the myeloproliferative syndrome.
    Weinfeld A; Branehög I; Kutti J
    Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
    [No Abstract]   [Full Text] [Related]  

  • 24. Membrane defects in inherited disorders of platelet function.
    White JG
    Am J Pediatr Hematol Oncol; 1982; 4(1):83-94. PubMed ID: 7091581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.
    Caranobe C; Sie P; Nouvel C; Laurent G; Pris J; Boneu B
    Scand J Haematol; 1980 Oct; 25(4):289-95. PubMed ID: 7209398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Congenital anomalies of the human blood platelet, models for understanding mechanisms of platelet secretion: gray platelet disease].
    Caen JP; Nurden AT; Levy-Toledano S
    C R Seances Acad Sci III; 1981 Oct; 293(7):363-6. PubMed ID: 6797688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelets in myeloproliferative disorders. III: Glycoprotein profile in relation to platelet function and platelet density.
    Eche N; Sie P; Caranobe C; Nouvel C; Pris J; Boneu B
    Scand J Haematol; 1981 Feb; 26(2):123-9. PubMed ID: 7256210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet abnormalities in diabetes mellitus.
    Glassman AB
    Ann Clin Lab Sci; 1993; 23(1):47-50. PubMed ID: 8431000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on the platelet dysfunction in chronic myeloproliferative syndromes.
    Vlădăreanu AM; Ciufu C; Bumbea H; Onisâi M; Aramă S
    Rom J Intern Med; 2008; 46(1):9-15. PubMed ID: 19157266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human gamma-thrombin: lack of correlation between a platelet functional response and glycoprotein V hydrolysis.
    Jandrot-Perrus M; Guillin MC; Nurden AT
    Thromb Haemost; 1987 Oct; 58(3):915-20. PubMed ID: 3433254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of platelet function.
    Day HJ; Rao AK
    Semin Hematol; 1986 Apr; 23(2):89-101. PubMed ID: 3010470
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic myeloproliferative disorders: a quantitative assessment of platelet ultrastructure.
    Boughton BJ; Jerrome DW; Rychetnik M
    Acta Haematol; 1980; 64(6):319. PubMed ID: 6782797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet function studies in myeloproliferative disorders.
    Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
    Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
    Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.
    Schafer AI
    N Engl J Med; 1982 Feb; 306(7):381-6. PubMed ID: 6799826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time.
    Baker RI; Manoharan A
    Eur J Haematol; 1988 Mar; 40(3):267-72. PubMed ID: 3356243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet dysfunction in acute leukemias and myelodysplastic syndromes.
    Vlădăreanu AM; Vasilache V; Bumbea H; Onisâi M
    Rom J Intern Med; 2011; 49(1):93-6. PubMed ID: 22026258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules.
    Gerrard JM; Phillips DR; Rao GH; Plow EF; Walz DA; Ross R; Harker LA; White JG
    J Clin Invest; 1980 Jul; 66(1):102-9. PubMed ID: 6156948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.